Glaukos Corporation (GKOS) vs Penumbra, Inc. (PEN)
Glaukos Corporation and Penumbra, Inc. are both Medical Devices companies. Penumbra, Inc. is the larger, with a market value of $12.6B against $9.1B — 1.4× the size. Glaukos Corporation has negative trailing earnings, so its P/E is not meaningful; Penumbra, Inc. trades at 78.0×. Glaukos Corporation grew revenue faster over the last twelve months: 41.6% against 17.6%. Penumbra, Inc. has the higher net margin (10.7% vs −30.7%) and the higher return on invested capital (13.1% vs −26.1%). Across the 18 metrics below, Penumbra, Inc. leads on 16 and Glaukos Corporation on 2.
Valuation
Profitability
| Metric | GKOS | PEN | Medical Devices median |
|---|---|---|---|
| Gross margin | 79.12% | 67.84% | 56.01% |
| Operating margin | (31.55%) | 12.45% | (15.03%) |
| Net margin | (30.68%) | 10.67% | (20.40%) |
| Free cash flow margin | (1.99%) | 14.35% | (7.24%) |
| Return on equity | (25.98%) | 11.37% | (15.32%) |
| Return on assets | (19.72%) | 8.80% | (19.72%) |
| Return on invested capital | (26.07%) | 13.13% | (10.33%) |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack